» Articles » PMID: 36098237

Influence of Bronchopulmonary Dysplasia on Lung Function in Adolescents Who Were Born Extremely Prematurely

Overview
Date 2022 Sep 13
PMID 36098237
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess if a previous diagnosis of bronchopulmonary dysplasia (BPD) was associated with poorer lung function at 16 to 19 years of age, regardless of whether postnatal corticosteroids had been administered.

Working Hypothesis: Infants with BPD will have poorer lung function at 16 to 19 years of age.

Study Design: Prospective follow-up study.

Patient-subject Selection: One hundred and sixty-one participants aged between 16 and 19 years who were born at less than 29 weeks of gestation; 87 had had BPD.

Methodology: Lung function was assessed by spirometry (FEV , FVC, FEV /FVC, FEF , FEF , FEF , FEF , PEF), impulse oscillometry (R5Hz and R20Hz), plethysmography (FRC , TLC , RV ), diffusion capacity of the lungs for carbon monoxide (D CO, D CO/VA) and lung clearance index (LCI). Questionnaires were used to quantify respiratory symptoms and a shuttle sprint test to assess exercise capacity.

Results: At 16 to 19 years, those who had had a diagnosis of BPD had poorer airway function (FEV , FEF , FEF , FEF ) compared to those without. FVC and D CO were also poorer in those who had BPD. Those differences remained significant after adjusting for sex, gestational age, and maternal smoking. When excluding those who had received postnatal corticosteroids, differences remained significant in FEV , FVC, and FEF . There were no significant differences in exercise capacity or respiratory symptoms between those with and without BPD.

Conclusions: In adolescents and young adults born prematurely, those who had BPD had poorer lung function compared to those without, regardless of whether they had received postnatal corticosteroids.

Citing Articles

Bioinformatic analysis reveals the relationship between macrophage infiltration and Cybb downregulation in hyperoxia-induced bronchopulmonary dysplasia.

He Y, Li D, Zhang M, Li F Sci Rep. 2024; 14(1):20089.

PMID: 39209930 PMC: 11362550. DOI: 10.1038/s41598-024-70877-7.


Prophylactic early low-dose hydrocortisone and survival without bronchopulmonary dysplasia among extremely preterm infants born at 22-27 weeks' gestation.

Shah S, Shukla S, Nandula P, Vice S, Elgendy M, Gautam S J Perinatol. 2024; 44(7):947-952.

PMID: 38459373 DOI: 10.1038/s41372-024-01923-5.


An Update on Lung Function of Extremely and Very Preterm Infants in Later Life: The Role of Early Nutritional Interventions.

Briana D, Malamitsi-Puchner A Nutrients. 2023; 15(15).

PMID: 37571290 PMC: 10421481. DOI: 10.3390/nu15153353.


Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely.

Harris C, Morris S, Lunt A, Peacock J, Greenough A Pediatr Pulmonol. 2022; 57(12):3151-3157.

PMID: 36098237 PMC: 9828792. DOI: 10.1002/ppul.26151.

References
1.
Nowowiejska B, Tomalak W, Radlinski J, Siergiejko G, Latawiec W, Kaczmarski M . Transient reference values for impulse oscillometry for children aged 3-18 years. Pediatr Pulmonol. 2008; 43(12):1193-7. DOI: 10.1002/ppul.20926. View

2.
Costeloe K, Hennessy E, Haider S, Stacey F, Marlow N, Draper E . Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ. 2012; 345:e7976. PMC: 3514472. DOI: 10.1136/bmj.e7976. View

3.
Harris C, Morris S, Lunt A, Peacock J, Greenough A . Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely. Pediatr Pulmonol. 2022; 57(12):3151-3157. PMC: 9828792. DOI: 10.1002/ppul.26151. View

4.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View

5.
Jobe A, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163(7):1723-9. DOI: 10.1164/ajrccm.163.7.2011060. View